AI Enabled Diagnostics Alimetry has recently launched an AI framework for gastric electrophysiology following FDA clearance in New Zealand, aimed at reducing movement-based artifacts and minimizing manual data corrections. This presents a cross-sell opportunity for enhanced data reliability and improved clinician efficiency across hospitals and clinics globally.

Global Hospital Rollout The AI update is being deployed to more than 50 hospitals and clinics worldwide in early 2026, indicating a growing international adoption footprint that sales teams can leverage to expand into new regions and health systems.

Wearable Diagnostics Alimetry’s wearable gut health device established a market presence with prior Series A funding and multiple funding rounds, signaling ongoing demand for noninvasive diagnostics and potential upsell of complementary wearables, data services, or integrated platforms.

Hi-Tech Industry Position Participation in the NZ Hi-Tech Awards reflects recognized industry relevance and credibility, providing a credible entry point for enterprise partnerships, research collaborations, and potential procurement opportunities within regional health tech networks.

Mid-Sized Growth With a revenue range of one to ten million and total funding of approximately thirty-five million, Alimetry sits in a growth phase that aligns well with scalable SaaS and services expansion, offering opportunities for channel partnerships, system integrators, and premium service contracts.